Well hopefully people get a positive surprise here, sphere25. It is certainly a non consensual call and at £8m valuation would come as a surprise to most. But I objectively think it has a lot going for it. GLA |
Ah, I remember now. Old lollywally bought 2/3 years ago at some multiple of todays price. And since then he has commentated, and postured, and spat out his dummy over and over. But what you'll never find lollywally doing is committing to a decision - is he now buying/selling/holding? Quite ironic for a poster who repeatedly chides the management capabilities of others |
Do you know when you go through the feed in the morning...and see an RNS like this...
"Immupharma PLC Breakthrough Findings into Autoimmune Diseases"
The eyes light up and you're sat there thinking...
"Wow! Maybe one of our tiddlers is about to set the market alight and provide some overdue euphoria. Almost anybody could trade on that and generate a return"
And then...
You read it and you're like...
"Hang on...what? I thought this was supposed to be some MEGA news. I mean, have they found a midget gem behind the sofa?"
So is this just a pump before a cash raise?
In the Land of De-Listing's, still sat waiting for those days when the odd few set the market on fire and go absolutely rocket ape...bananana....rama.
Those days when there used to be hundreds and hundreds of posts a day on a single forum.
Surely something out there is going to surprise amongst the majority of de-listings to come.
Surely? |
Also, I believe chairman TM marched this tiny uk biotech all the way to completion of a phase 3 in a blockbuster indication. Not too bad then. |
I recall you had an investment here, lordlolly. Are you still invested? |
This dog will drop I am with Nobby....! Nothing RNS & will be dumped into.... |
All very well saying don't judge a share through the rear view mirror.
However, barring a Board shakeup, that's often the only real indicator of a Director's track record. TM has a proud history of marching shareholders up to the top of the hill and marching them down again.
This RNS has all the hallmarks of Tim's usual puffery. Create excitement, make it sound like you're on the cusp of something huge, then reveal a hitch, followed by radio silence for another eternity. Look at Incanthera if you don't believe me. |
I'm already in Wig -
I think there will be patents coming to fruition here for the data they have -
It be interesting to see how they use this data because clearly they are not saying anything at the moment - |
Depends who has it tomboy, and for what purpose |
"But Nobby may well be right." The market cap is £8m, and if nobs consensual view is right you might lose some money, tomboy. But the key thing to consider from this valuation is - what happens to the share price if he is wrong... ATB |
Wig nothing wrong with having Pharmacological knowledge - |
Its Generic and not specific I think to P140 but there may well be patents on the way -
Gotta dash but if there is anything of what their title says then it could well be a beast - |
For the record, I couldn't care less about nobs scientific analysis. There was an opportunity to ride a multi bagger here prior to the last phase 3 readout, and along with many others I took it. But nob did not take it. This is an investment board. If you want plaudits for science, look elsewhere. |
I was just going to ask your opinion Nobby -
IMM have data correlating to auto-immune mechanisms. And will be increasing a number of patents for P140.
I presume this is specific to P140 not generic (although it sounds it) -
No release of data due to patent pending? - |
For the record wiggy tried really hard to discredit my scientific analysis and failed miserably. That’s the truth…
A few people may have made money on a lucky punt this morning but if you have, you should be dumping now! This is a nothing announcement… |
I think there will be interest TBH -
If what they say they have then the market cap is dwarfed -
Its a gamble because they have refused to release the data that shows the mechanisms of autoimmune response particularly when it comes to P140 -
The biotech industry may well be paying attention here - |
I'm sure some will make some money here, long/short etc, however be under no illusions, the RNS says nothing of any consequence. I'd leave them to it Nobby. |
The Company is not at this time releasing detailed data as these findings form part of the ongoing expansion of our intellectual property portfolio including additional patents for P140. |
The title is incredibly significant -
But Nobby may well be right. Where is the detail - ?
If there was a breakthrough in auto-immune finding it would be ground breaking - |
Actually I trashed your market knowledge, nob. And I was right. The stock multiplied prior to trial readout and many profited (but not you). |
not a good show deramping when people are making money! Shows bitterness |
Tim is a serial failure whilst getting recompensed very well himself with his multiple directorships. Even Incanthera where I actually doubled my money has now crashed after a patent issue… |
Just for the record wiggy trashed my scientific analysis and was extremely rude. Of course he was wrong and strangely the FDA agree with me! |
Anyone remember Tim from the good old Alizyme days? |
The gullible are being mugged waterloo…..placing ahoy! |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
